View in EDS

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis.

Saved in:
Bibliographic Details
Title: Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis.
Authors: Ahmad T; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Adil M; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Azharuddin M; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Ansari S; Institute of Health Management Research - Bangalore, Karnataka 560105, India., Vohora D; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Sharma M; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Source: Current reviews in clinical and experimental pharmacology [Curr Rev Clin Exp Pharmacol] 2025 Jul 09. Date of Electronic Publication: 2025 Jul 09.
Publication Type: Journal Article; Meta-Analysis
Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 9918227368306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-4336 (Electronic) Linking ISSN: 27724328 NLM ISO Abbreviation: Curr Rev Clin Exp Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-4336
DOI:10.2174/0127724328373328250624065307